Publications by authors named "Antonia Partl"

Claim this Profile
R
Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.
Ray Manneh Kopp, Francesco Massari, Enrique Grande, Timothy J Schieber, Yüksel Ürün, Antonia Partl

Cancer Immunol Immunother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case report.
Nils C H van Creij, Gerald Klinglmair, Leonhard Gruber, Antonia Partl, Alain G Zeimet

Ther Adv Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis